TOLEDO, Ohio — The University of Toledo College of Medicine and Life Sciences received a four-year, $2.32 million grant from the National Institutes of Health to study a serious, and often deadly, lung condition.
What You Need To Know
- The study will focus on acute lung injury
- It’ll look at the process of why immune cells continue to work when they no longer need to, which ends up causing acute lung injury
- The team will also look into the possibility of repurposing a medication as a possible treatment
The study will focus on acute lung injury and will also research repurposing a common asthma medication as a new way to treat it, according to the University of Toledo.
The university explained that when lungs are exposed to airborne pathogens, they start an immune response to help fight the contaminants. However, sometimes, the immune cells keep fighting, resulting in organ damage and breathing failure…